logo
  

Bosch To Buy Siemens' 50% Stake In BSH JV For About EUR 3 Bln

Bosch and German conglomerate Siemens AG (SIEGY) agreed that Robert Bosch GmbH will acquire Siemens' 50 percent stake in the joint venture BSH Bosch und Siemens Hausgeräte GmbH or BSH. The purchase price will total 3 billion euros. In addition, Siemens and Bosch will each receive from BSH an additional distribution of 250 million euros before the transaction is completed.

The transaction has been approved by the Board of Management and Supervisory Board of Bosch and the Managing Board and Supervisory Board of Siemens.

The transaction, which still requires regulatory approval, will probably be completed in the first half of calendar year 2015. BSH will then become a wholly owned subsidiary of the Bosch Group.

As per the terms of the agreement, BSH will also be allowed to produce and market household appliances under the Siemens brand over the long term.

In 1967, Bosch and Siemens combined their activities in the area of household appliances to create the joint venture BSH.

On Sunday, US oilfield equipment maker Dresser-Rand Group Inc. (DRC) agreed to be acquired by German conglomerate Siemens for $83.00 per share in an all-cash deal valued at about $7.6 billion, including assumed debt.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Mukilteo, Washington-based Ivar's Soup and Sauce Co. is recalling 14,968 sleeves of refrigerated Kettle Classic Clam Chowder With Uncured Bacon citing the possible presence of hard, sharp opaque plastic pieces, the U.S Foof and Drug Administration said. The products were sold exclusively at Costco stores. The U.S. Food and Drug Administration (FDA) approved Boehringer Ingelheim's Cyltezo as the first interchangeable biosimilar to AbbVie's top-selling drug Humira or adalimumab. Cyltezo, originally approved in August 2017, is both biosimilar to, and interchangeable with Humira for Cyltezo's approved uses. The Food and Drug Administration may be planning to allow people to receive Covid-19 vaccine booster shot that is different from the initial dose, reports indicate. The agency is likely to make the announcement on mix and match approach on coronavirus booster vaccines on Wednesday. The move will be part of FDA's expected authorization of boosters for the Moderna and Johnson & Johnson vaccines.
RELATED NEWS
Follow RTT